The Federal Court Appeals Decision Will Cost You
On Tuesday, a federal appeals court ruled that biosimilar drug makers must always notify their brand-name rivals six months before
Read More
Legislative Update
The New Oncology Care Model
On July 1st, the Centers of Medicare and Medicaid (CMS) launched the new five year Oncology Care Model aimed at
Read MoreNew Guidelines not Regulation for Conflict of Interest
The US Food and Drug Administration have issued a draft guidance spelling out circumstances when the appearance of a conflict
Read MoreHHS Announces Physician Groups Selected for an Initiative Promoting Better Cancer Care
(Source – www.hhs.gov) HHS Oncology Care Model attracts almost twice the expected number of physician group practices The U.S. Department
Read MorePro-Lifers on Supreme Court Abortion Case: ‘We’re Coming Back in Full Force’
(By Leah Jessen for The Daily Signal) Members of the pro-life movement standing outside the Supreme Court on Monday were
Read MoreSupreme Court Strikes Down Key Restrictions In Texas Anti-Abortion Law
(By Julie Rovner for Kaiser Health News) The Supreme Court struck down key aspects of a Texas abortion law Monday,
Read MorePrice Relief, Innovation, and Competition for Essential Drugs Act will it Lower Drug Costs?
U.S. Representative Janice Schakowsky, (D-IL 9th District), introduced the bill called Price Relief, Innovation, and Competition for Essential Drugs Act
Read MoreZika Virus Funding in Limbo
Eric Schultz, deputy White House press secretary says that President Obama would veto the $1.1 billion Zika funding package The
Read MoreFirst Use of CRISPR Wins Approval
In a follow up to article posted on June 20, 2016, CRISPR Up for Federal Review. On Tuesday, a federal biosafety
Read MoreThe Administration to Help the Supreme Court Decide on a Case
The U.S. Supreme Court has asked the Obama administration for its views on a rule (Biologics Price Competition and Innovation
Read More